R
Robert J. Turner
Researcher at Novartis
Publications - 4
Citations - 235
Robert J. Turner is an academic researcher from Novartis. The author has contributed to research in topics: Salmeterol & Indacaterol. The author has an hindex of 4, co-authored 4 publications receiving 222 citations.
Papers
More filters
Journal ArticleDOI
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
Cliff H. Battram,Steven J. Charlton,Bernard Cuenoud,Mark R Dowling,Robin Alec Fairhurst,David Farr,John R. Fozard,Juliet Leighton-Davies,Christine Lewis,Lorraine McEvoy,Robert J. Turner,Alexandre Trifilieff +11 more
TL;DR: The preclinical profile of indacaterol suggests that this compound has a superior duration of action compatible with once-daily dosing in human, together with a fast onset of action and an improved cardiovascular safety profile over marketed inhaled β2 adrenoceptor agonists.
Journal ArticleDOI
Efficacy is a contributing factor to the clinical onset of bronchodilation of inhaled β2-adrenoceptor agonists
TL;DR: It is demonstrated that the rate of cAMP accumulation is influenced by agonist efficacy and that this, in combination with lipophilicity, may explain why β2 AR agonists demonstrate differences in their onset of action.
Journal ArticleDOI
Assessing the minimum number of data points required for accurate IC50 determination.
TL;DR: This study shows that it is possible to generate IC50 values from an appropriately designed primary inhibition screen using two compound concentrations, reducing the requirement for follow-up IC50 determinations.
Journal ArticleDOI
Synthesis and evaluation of two series of 4'-aza-carbocyclic nucleosides as adenosine A2A receptor agonists.
David Beattie,Andrew Brearley,Zarin Brown,Steven J. Charlton,Brian Cox,Robin Alec Fairhurst,John R. Fozard,Peter Gedeck,Paul Kirkham,Koremu Meja,Lana Nanson,James Neef,Helen Oakman,Gillian Spooner,Roger J. Taylor,Robert J. Turner,Ryan West,Hannah Woodward +17 more
TL;DR: The propionamides 14-18 and the 4-hydroxymethylpyrazole 32 were determined to be the most potent and selective examples from the 4'-reversed amide and 4'-N-bonded heterocyclic series, respectively.